LOC105369213: A Drug Target / Disease Biomarker (G105369213)
LOC105369213: A Drug Target / Disease Biomarker
LOC105369213 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of transmembrane protein (SMP), which includes a group of proteins that are characterized by the presence of a transmembrane region and intracellular loops.
LOC105369213 is of particular interest as a potential drug target or biomarker because of its involvement in a number of important biological processes. For example, it has been shown to be involved in the regulation of inflammation, which is a critical function for many diseases, including cardiovascular disease and neuroinflammatory disorders.
In addition, LOC105369213 has also been shown to play a role in the regulation of cell survival and metabolism. This is important because many diseases, including neurodegenerative disorders, are characterized by the breakdown of normal cellular processes that are essential for cell survival and function.
LOC105369213 is also of interest as a potential drug target because of its involvement in the regulation of signaling pathways that are involved in many diseases, including cancer. For example, studies have shown that LOC105369213 is involved in the regulation of the PI3K/Akt signaling pathway, which is a critical pathway involved in the regulation of many cellular processes, including cell growth, survival, and metabolism.
In addition, LOC105369213 has also been shown to play a role in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of many cellular processes, including inflammation and immune responses. This is important because many diseases, including neuroinflammatory disorders, are characterized by the activation of these signaling pathways and the disruption of normal cellular processes.
LOC105369213 is of particular interest as a potential drug target because of its involvement in the regulation of the blood-brain barrier (BBB), which is a critical barrier that separates the brain from the body and helps to protect it from many harmful substances. The BBB is made up of many different proteins, including LOC105369213, and is involved in the regulation of many important cellular processes, including the movement of nutrients, waste products, and other substances into and out of the brain.
In addition, LOC105369213 has also been shown to play a role in the regulation of the endothelial cell, which is a type of blood cell that plays a critical role in maintaining the blood-brain barrier. This is important because the endothelial cells of the BBB are involved in the regulation of many important cellular processes, including the regulation of blood flow and the production of factors that are involved in the formation of the BBB.
LOC105369213 is of particular interest as a potential drug target because of its involvement in the regulation of the immune response. The immune response is a critical function of the body, and is involved in the regulation of many important cellular processes, including the detection and response to foreign substances, such as bacteria, viruses, and other pathogens.
In addition, LOC105369213 has also been shown to play a role in the regulation of the inflammation response. This is important because many diseases, including cardiovascular disease and neuroinflammatory disorders, are characterized by the inflammation response being activated and out of control.
LOC105369213 is of particular interest as a potential drug target because of its involvement in the regulation of the DNA damage response (DDR), which is a critical
Protein Name: Uncharacterized LOC105369213
The "LOC105369213 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105369213 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105369250 | LOC105369302 | LOC105369308 | LOC105369309 | LOC105369312 | LOC105369315 | LOC105369325 | LOC105369326 | LOC105369366 | LOC105369367 | LOC105369368 | LOC105369380 | LOC105369384 | LOC105369388 | LOC105369391 | LOC105369395 | LOC105369401 | LOC105369410 | LOC105369441 | LOC105369455 | LOC105369456 | LOC105369464 | LOC105369501 | LOC105369506 | LOC105369513 | LOC105369530 | LOC105369531 | LOC105369566 | LOC105369568 | LOC105369572 | LOC105369574 | LOC105369603 | LOC105369612 | LOC105369614 | LOC105369617 | LOC105369623 | LOC105369625 | LOC105369628 | LOC105369639 | LOC105369645 | LOC105369655 | LOC105369663 | LOC105369689 | LOC105369698 | LOC105369705 | LOC105369709 | LOC105369710 | LOC105369732 | LOC105369735 | LOC105369736 | LOC105369743 | LOC105369749 | LOC105369750 | LOC105369761 | LOC105369765 | LOC105369772 | LOC105369775 | LOC105369777 | LOC105369780 | LOC105369781 | LOC105369798 | LOC105369806 | LOC105369818 | LOC105369823 | LOC105369830 | LOC105369833 | LOC105369835 | LOC105369838 | LOC105369843 | LOC105369844 | LOC105369850 | LOC105369862 | LOC105369869 | LOC105369879 | LOC105369890 | LOC105369896 | LOC105369923 | LOC105369927 | LOC105369928 | LOC105369944 | LOC105369958 | LOC105369965 | LOC105369976 | LOC105369998 | LOC105370002 | LOC105370003 | LOC105370011 | LOC105370025 | LOC105370027 | LOC105370032 | LOC105370050 | LOC105370073 | LOC105370076 | LOC105370108 | LOC105370109 | LOC105370113 | LOC105370115 | LOC105370127 | LOC105370128 | LOC105370134
